The Technical Analyst
Select Language :
Catalyst Pharmaceuticals [CPRX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Catalyst Pharmaceuticals Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Catalyst Pharmaceuticals is listed at the  Exchange

-2.03% $15.94

America/New_York / 28 mar 2024 @ 16:00


Catalyst Pharmaceuticals: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 1 878.74 mill
EPS: 0.630
P/E: 25.30
Earnings Date: May 07, 2024
SharesOutstanding: 117.86 mill
Avg Daily Volume: 1.511 mill
RATING 2024-03-28
A+
Strong Buy
RATINGS
Rating CashFlow: Neutral
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Sell
P/E: Strong Buy
Price To Book: Strong Buy
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE 25.30 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
4.30x
Company: PE 25.30 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 15.25 - 16.63

( +/- 4.35%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-03-27 Elsbernd Brian Sell 25 000 Common stock, par value $0.001 per share
2024-02-15 Del Carmen Jeffrey Sell 10 667 Restricted Stock Units
2024-02-15 Del Carmen Jeffrey Buy 10 667 Common stock, par value $0.001 per share
2024-02-15 Del Carmen Jeffrey Sell 3 125 Common stock, par value $0.001 per share
2024-02-15 Daly Richard J Sell 4 000 Restricted Stock Units
INSIDER POWER
38.45
Last 100 transactions
Buy: 3 301 722 | Sell: 1 453 545

Forecast: 16:00 - $15.93

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $15.93
Forecast 2: 16:00 - $15.93
Forecast 3: 16:00 - $15.93
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $15.94 (-2.03% )
Volume 1.124 mill
Avg. Vol. 1.511 mill
% of Avg. Vol 74.40 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Catalyst Pharmaceuticals Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Catalyst Pharmaceuticals Inc

RSI

Intraday RSI14 chart for Catalyst Pharmaceuticals Inc

Last 10 Buy & Sell Signals For CPRX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35sell$13.41N/AActive
Profile picture for
            Catalyst Pharmaceuticals Inc

CPRX

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis, and spinal muscular atrophy type 3, as well as to treat hereditary neuropathy with liability to pressure palsies. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. The company was formerly known as Catalyst Pharmaceutical Partners, Inc. and changed its name to Catalyst Pharmaceuticals, Inc. in May 2015. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Last 10 Buy Signals

Date Signal @
WLDUSDMar 28 - 19:538.41
NMRUSDMar 28 - 19:55$37.64
NOSUSDMar 28 - 19:544.27
BURGERUSDMar 28 - 19:530.898
ZRXUSDMar 28 - 19:53$1.046
SNBNBUSDMar 28 - 19:49586.28
ARKMUSDMar 28 - 19:532.74
ATOMUSDMar 28 - 19:53$12.29
ONTUSDMar 28 - 19:49$0.372
CFXUSDMar 28 - 19:48$0.478

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.